Neurocrine Biosciences
Price & Volume
Stats
See more52W Range | $121.42-$162.39 |
Market Cap | $15.6B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $3.1B |
Revenue Growth (YoY) | 42.2% |
Gross Profit (12 Mos) | $1.9B |
Diluted EPS | $6.50 |
News
See moreYahoo Finance • 3 days ago
Neurocrine Biosciences to Present at Upcoming Investor Conferences in June
Yahoo Finance • 9 days ago
A Look At Neurocrine Biosciences (NBIX) Valuation As New INGREZZA Real World Data Gains Attention
Yahoo Finance • 10 days ago
Neurocrine Unveils New INGREZZA Findings In Mild Tardive Dyskinesia At APA 2026; Closes Soleno Deal
Yahoo Finance • 24 days ago
Neurocrine Biosciences Reports First-Quarter 2026 Financial Results
About
CEO | Mr. Kyle W. Gano Ph.D. |
Address | 6027 Edgewood Bend Court, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 2,000 |